Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201734516> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3201734516 abstract "Abstract Background This study aimed to determine the safety and efficacy of different doses of tandospirone to treat generalized anxiety disorder (GAD). Methods This parallel randomized controlled trial involved patients with GAD from eight centers in China between 01/2012 and 09/2018. Patients were randomly assigned to 60 mg/day and 30 mg/day groups. The primary endpoint was the overall response rate at the end of week 6. The secondary endpoints included significant response rate, change in Hamilton Anxiety Scale (HAMA) total score, HAMA subscale score, Hamilton Depression Scale-17 (HAMD-17), and adverse drug reactions. Results No significant difference was found in the overall response rate (65.7% vs 58.4%, P > 0.05) between 60 mg/day and 30 mg/day groups. The significant response rate (34.3% vs 22.6%, P = 0.032) was better in the 60 mg/day group. The reduction in HAMA total score, somatic anxiety factor, cardiovascular symptom factor, gastrointestinal symptom factor, and HAMD-17 score were better in the 60 mg/day group (all P < 0.05). The incidence of dizziness and gastrointestinal reactions of the 60 mg/day group was higher than that of the 30 mg/day group. However, there was no significant difference in the proportion of withdrawal due to adverse events. Conclusions For GAD treatment, the overall response rate of high-dose tandospirone was similar to that of low-dose tandospirone. The safety in the two groups was tolerable. Patients with good compliance might benefit from a high-dose regimen. Trial registration: The trial registration no. was NCT01614041(07/06/2012)." @default.
- W3201734516 created "2021-10-11" @default.
- W3201734516 creator A5003600381 @default.
- W3201734516 creator A5005940680 @default.
- W3201734516 creator A5013105710 @default.
- W3201734516 creator A5027835055 @default.
- W3201734516 creator A5030760079 @default.
- W3201734516 creator A5037105069 @default.
- W3201734516 creator A5058123025 @default.
- W3201734516 creator A5059766369 @default.
- W3201734516 creator A5074974180 @default.
- W3201734516 creator A5085548672 @default.
- W3201734516 creator A5088507691 @default.
- W3201734516 date "2021-10-05" @default.
- W3201734516 modified "2023-09-26" @default.
- W3201734516 title "Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial" @default.
- W3201734516 doi "https://doi.org/10.21203/rs.3.rs-800448/v1" @default.
- W3201734516 hasPublicationYear "2021" @default.
- W3201734516 type Work @default.
- W3201734516 sameAs 3201734516 @default.
- W3201734516 citedByCount "0" @default.
- W3201734516 crossrefType "posted-content" @default.
- W3201734516 hasAuthorship W3201734516A5003600381 @default.
- W3201734516 hasAuthorship W3201734516A5005940680 @default.
- W3201734516 hasAuthorship W3201734516A5013105710 @default.
- W3201734516 hasAuthorship W3201734516A5027835055 @default.
- W3201734516 hasAuthorship W3201734516A5030760079 @default.
- W3201734516 hasAuthorship W3201734516A5037105069 @default.
- W3201734516 hasAuthorship W3201734516A5058123025 @default.
- W3201734516 hasAuthorship W3201734516A5059766369 @default.
- W3201734516 hasAuthorship W3201734516A5074974180 @default.
- W3201734516 hasAuthorship W3201734516A5085548672 @default.
- W3201734516 hasAuthorship W3201734516A5088507691 @default.
- W3201734516 hasBestOaLocation W32017345161 @default.
- W3201734516 hasConcept C118552586 @default.
- W3201734516 hasConcept C120665830 @default.
- W3201734516 hasConcept C121332964 @default.
- W3201734516 hasConcept C126322002 @default.
- W3201734516 hasConcept C162156334 @default.
- W3201734516 hasConcept C168563851 @default.
- W3201734516 hasConcept C197934379 @default.
- W3201734516 hasConcept C203092338 @default.
- W3201734516 hasConcept C2777198177 @default.
- W3201734516 hasConcept C2781413609 @default.
- W3201734516 hasConcept C2993089816 @default.
- W3201734516 hasConcept C42219234 @default.
- W3201734516 hasConcept C558461103 @default.
- W3201734516 hasConcept C61511704 @default.
- W3201734516 hasConcept C71924100 @default.
- W3201734516 hasConceptScore W3201734516C118552586 @default.
- W3201734516 hasConceptScore W3201734516C120665830 @default.
- W3201734516 hasConceptScore W3201734516C121332964 @default.
- W3201734516 hasConceptScore W3201734516C126322002 @default.
- W3201734516 hasConceptScore W3201734516C162156334 @default.
- W3201734516 hasConceptScore W3201734516C168563851 @default.
- W3201734516 hasConceptScore W3201734516C197934379 @default.
- W3201734516 hasConceptScore W3201734516C203092338 @default.
- W3201734516 hasConceptScore W3201734516C2777198177 @default.
- W3201734516 hasConceptScore W3201734516C2781413609 @default.
- W3201734516 hasConceptScore W3201734516C2993089816 @default.
- W3201734516 hasConceptScore W3201734516C42219234 @default.
- W3201734516 hasConceptScore W3201734516C558461103 @default.
- W3201734516 hasConceptScore W3201734516C61511704 @default.
- W3201734516 hasConceptScore W3201734516C71924100 @default.
- W3201734516 hasLocation W32017345161 @default.
- W3201734516 hasOpenAccess W3201734516 @default.
- W3201734516 hasPrimaryLocation W32017345161 @default.
- W3201734516 hasRelatedWork W2020073008 @default.
- W3201734516 hasRelatedWork W2333886711 @default.
- W3201734516 hasRelatedWork W2353263566 @default.
- W3201734516 hasRelatedWork W2368915719 @default.
- W3201734516 hasRelatedWork W2388390772 @default.
- W3201734516 hasRelatedWork W2394341731 @default.
- W3201734516 hasRelatedWork W2914922310 @default.
- W3201734516 hasRelatedWork W3032736394 @default.
- W3201734516 hasRelatedWork W3033541525 @default.
- W3201734516 hasRelatedWork W3083937373 @default.
- W3201734516 isParatext "false" @default.
- W3201734516 isRetracted "false" @default.
- W3201734516 magId "3201734516" @default.
- W3201734516 workType "article" @default.